Status:
UNKNOWN
Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Novosibirsk Region
Lead Sponsor:
Novosibirsk Scientific Research Institute for Circulatory Pathology
Conditions:
Chronic Thromboembolic Pulmonary Hypertension
Eligibility:
All Genders
18-80 years
Brief Summary
There will be assessment of patients after acute pulmonary embolism for the development of CTEPH
Detailed Description
There will be assessment of patients after acute pulmonary embolism for the development of CTEPH. There will be analysis of case histories of 40 patients with acute pulmonary embolism. All this patie...
Eligibility Criteria
Inclusion
- patients who had episodes of acute pulmonary embolism
- 3-4 months of anticoagulation treatment after acute pulmonary embolism
- informed consent
Exclusion
- pregnancy
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 10 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03349164
Start Date
January 1 2017
End Date
March 10 2018
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novosibirsk research institute of circulation pathology
Novosibirsk, Novosibirsk Oblast, Russia, 630055